Annals of Surgical Oncology

, Volume 20, Issue 1, pp 318–324

Surgical Resection after Downsizing Chemotherapy for Initially Unresectable Locally Advanced Biliary Tract Cancer: A Retrospective Single-center Study

Authors

    • Department of General SurgeryChiba University Graduate School of Medicine
  • Hiroaki Shimizu
    • Department of General SurgeryChiba University Graduate School of Medicine
  • Masayuki Ohtsuka
    • Department of General SurgeryChiba University Graduate School of Medicine
  • Hiroyuki Yoshidome
    • Department of General SurgeryChiba University Graduate School of Medicine
  • Hideyuki Yoshitomi
    • Department of General SurgeryChiba University Graduate School of Medicine
  • Katsunori Furukawa
    • Department of General SurgeryChiba University Graduate School of Medicine
  • Dan Takeuchi
    • Department of General SurgeryChiba University Graduate School of Medicine
  • Tsukasa Takayashiki
    • Department of General SurgeryChiba University Graduate School of Medicine
  • Fumio Kimura
    • Department of General SurgeryChiba University Graduate School of Medicine
  • Masaru Miyazaki
    • Department of General SurgeryChiba University Graduate School of Medicine
Hepatobiliary Tumors

DOI: 10.1245/s10434-012-2312-8

Cite this article as:
Kato, A., Shimizu, H., Ohtsuka, M. et al. Ann Surg Oncol (2013) 20: 318. doi:10.1245/s10434-012-2312-8

Abstract

Background

Surgical resection is the only method for curative treatment of biliary tract cancer (BTC). Recently, an improved efficacy has been revealed in patients with initially unresectable locally advanced BTC to improve the prognosis by the advent of useful cancer chemotherapy. The aim of this study was to evaluate the effect of downsizing chemotherapy in patients with initially unresectable locally advanced BTC.

Methods

Initially unresectable locally advanced cases were defined as those in which therapeutic resection could not be achieved even by proactive surgical resection. Gemcitabine was administered intravenously once a week for 3 weeks followed by 1 week’s respite. Patients whose disease responded to chemotherapy were reevaluated to determine whether their tumor was resectable.

Results

Chemotherapy with gemcitabine was provided to 22 patients with initially unresectable locally advanced BTC. Tumor was significantly downsized in nine patients, and surgical resection was performed in 8 (36.4%) of 22 patients. Surgical resection resulted in R0 resection in four patients and R1 resection in four patients. Patients who underwent surgical resection had a significantly longer survival compared with those unable to undergo surgery.

Conclusions

Preoperative chemotherapy enables the downsizing of initially unresectable locally advanced BTC, with radical resection made possible in a certain proportion of patients. Downsizing chemotherapy should be proactively carried out as a multidisciplinary treatment strategy for patients with initially unresectable locally advanced BTC with the aim of expanding the surgical indication.

Copyright information

© Society of Surgical Oncology 2012